These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15273152)

  • 1. Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniae.
    Jacoby GA; Mills DM; Chow N
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3203-6. PubMed ID: 15273152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative activity of ertapenem against extended-spectrum beta-lactamase-producing or plasmid-mediated AmpC beta-lactamase-producing Klebsiella pneumoniae].
    Hernández JR; Conejo Mdel C; Pascual A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):27-30. PubMed ID: 19631421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
    Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
    J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics profiling of ertapenem challenged major porin deficient carbapenem-resistant Klebsiella pneumoniae.
    Yuan PB; Ling JH; Zhu JH; Peng C; Chen EZ; Zhong YX; Liu WT; Wang LJ; Yang L; Chen DQ
    J Proteomics; 2022 Sep; 268():104715. PubMed ID: 36058541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.
    Leavitt A; Chmelnitsky I; Colodner R; Ofek I; Carmeli Y; Navon-Venezia S
    J Clin Microbiol; 2009 Apr; 47(4):969-74. PubMed ID: 19213695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.
    Poulou A; Voulgari E; Vrioni G; Koumaki V; Xidopoulos G; Chatzipantazi V; Markou F; Tsakris A
    J Clin Microbiol; 2013 Oct; 51(10):3176-82. PubMed ID: 23850951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Contributes to the Minimum Inhibitory Concentration? Beyond β-Lactamase Gene Detection in Klebsiella pneumoniae.
    Maclean AKW; Morrow S; Niu F; Hanson ND
    J Infect Dis; 2024 Oct; 230(4):e777-e788. PubMed ID: 38654105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
    Doumith M; Ellington MJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):659-67. PubMed ID: 19233898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.
    Elliott E; Brink AJ; van Greune J; Els Z; Woodford N; Turton J; Warner M; Livermore DM
    Clin Infect Dis; 2006 Jun; 42(11):e95-8. PubMed ID: 16652304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
    Cai JC; Zhou HW; Zhang R; Chen GX
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant.
    García-Fernández A; Miriagou V; Papagiannitsis CC; Giordano A; Venditti M; Mancini C; Carattoli A
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4178-84. PubMed ID: 20660683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
    Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
    Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli.
    Girlich D; Poirel L; Nordmann P
    Antimicrob Agents Chemother; 2009 Feb; 53(2):832-4. PubMed ID: 19029330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
    Hernández JR; Velasco C; Romero L; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2006 Nov; 28(5):457-9. PubMed ID: 17008066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
    Tängdén T; Adler M; Cars O; Sandegren L; Löwdin E
    J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
    Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.
    Martínez-Martínez L; Pascual A; Hernández-Allés S; Alvarez-Díaz D; Suárez AI; Tran J; Benedí VJ; Jacoby GA
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1669-73. PubMed ID: 10390220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.